Biomedical evidence, comprehensively covered
Embase (embase.com) earns a Brand Analyzer score of 72 out of 100, placing it in the Brand-Ready tier among Healthcare brands, Education brands, Technology brands. Among 4076 Healthcare brands analyzed, Embase ranks in the 46th percentile (category average 73, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 90/100, Digital Presence 100/100, Visual Identity 83/100, Messaging Clarity 95/100, Trust Foundation 70/100, AI Discoverability 35/100, Brand Authority 35/100.
Embase is a biomedical database designed to help researchers and healthcare professionals quickly find relevant scientific evidence. It combines MEDLINE content with additional indexed journals, conference abstracts, and preprints, and uses Emtree indexing along with advanced search and filtering tools. Embase serves biomedical researchers, pharmaceutical and life sciences professionals, healthcare practitioners, systematic reviewers, and academic institutions seeking comprehensive, evidence-based literature research, including for pharmacovigilance purposes.
| Brand Name | Embase |
|---|---|
| Domain | embase.com |
| Industry | Healthcare, Education |
| Main Competitors | PubMed/MEDLINE, Scopus (85/100), Web of Science (82/100), Cochrane Library (69/100), Ovid, ProQuest |
Moz Domain Authority 51/100 vs category average 37 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #236,516 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Embase appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "To help researchers and healthcare professionals quickly find relevant biomedical evidence to support better health outcomes." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn, Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Embase scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Embase has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (50/100) and its weakest is trust (22/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #236,516 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Embase from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Embase?", Claude could identify the brand as of August 2026. Embase is a biomedical literature database owned by Elsevier, widely used by pharmaceutical companies, researchers, and healthcare professionals for systematic reviews, drug research, and literature surveillance because it indexes journals, conference abstracts, and includes MEDL Best known for Comprehensive biomedical and pharmacological literature database used for systematic reviews and drug safety research.
When asked "Best brands similar to Embase?", Claude would recommend Embase as of August 2026. It's a leading tool in biomedical literature searching, especially valued for its strong pharmacovigilance and conference abstract coverage compared to PubMed.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Embase's main competitors include PubMed/MEDLINE, Scopus (85/100), Web of Science (82/100), Cochrane Library, Ovid. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Embase and Scopus are competitors in Healthcare. Brand Analyzer scores Embase at 72/100 and Scopus at 85/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Embase include PubMed/MEDLINE, Scopus (85/100), Web of Science (82/100), Cochrane Library, Ovid. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Embase has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 40, trust 22, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Embase official site
Embase offers a biomedical literature database that includes MEDLINE content, additional indexed journals, conference abstracts, and preprints. It provides advanced search and filtering capabilities, supported by Emtree indexing, a specialized biomedical thesaurus that enhances the accuracy and relevance of search results for users conducting literature reviews or evidence-based research.
Sources: Embase official site
Embase scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Embase official site
Embase is a biomedical database that provides access to a wide range of scientific literature, including journal articles, conference abstracts, and preprints. It is designed to help researchers and healthcare professionals find relevant biomedical evidence efficiently. Embase combines MEDLINE content with additional indexed sources and uses Emtree, a specialized biomedical thesaurus, to enhance search precision. It is positioned as a comprehensive resource for life sciences professionals, pharmacovigilance teams, and academic institutions conducting evidence-based research.
Sources: Embase official site
Embase functions as a searchable database that aggregates biomedical literature from journals, conference abstracts, and preprints. It enables users to search, filter, and retrieve relevant scientific evidence using advanced tools such as Emtree indexing, which standardizes biomedical terminology for more precise results. This supports tasks such as literature reviews, systematic reviews, and pharmacovigilance monitoring by allowing users to efficiently locate research relevant to their specific biomedical or clinical questions.
Sources: Embase official site
Embase can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Embase official site
Embase is used by biomedical researchers, pharmaceutical and life sciences professionals, healthcare practitioners, systematic reviewers, and academic institutions. These users rely on Embase to conduct comprehensive literature research, support evidence-based decision-making, and monitor pharmacovigilance data within the biomedical and healthcare fields.
Sources: Embase official site
Embase is known for its comprehensive coverage of biomedical literature, combining MEDLINE content with additional indexed journals, conference abstracts, and preprints. It is particularly recognized for its Emtree indexing system, which provides structured biomedical terminology to improve search accuracy. This depth and precision make it a valued resource among researchers and professionals conducting systematic reviews and evidence-based research in the life sciences and pharmaceutical fields.
Sources: Embase official site
Embase is used by researchers and healthcare professionals because it offers unparalleled depth of biomedical literature, combining MEDLINE content with additional indexed journals, conference abstracts, and preprints. Its advanced search and filtering tools, including Emtree indexing, allow users to quickly and accurately locate relevant biomedical evidence. This comprehensiveness and precision make it a preferred tool for systematic reviewers, pharmacovigilance teams, and academic institutions requiring thorough literature research.
Sources: Embase official site
Ranked closest to Embase: DSN Software (72/100), drtalk (72/100), emedpractice (72/100), Emprise (72/100).
A step up - brands to learn from: Zurich Insurance Group (81/100), Zimmer Biomet (81/100).
Category leader: Elsevier (96/100).